Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Research & Development (2017 - 2025)

Neuronetics (STIM) has disclosed Research & Development for 9 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development fell 37.75% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.7 million, a 16.07% increase, with the full-year FY2024 number at $12.8 million, up 34.22% from a year prior.
  • Research & Development was $1.5 million for Q3 2025 at Neuronetics, down from $1.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.8 million in Q4 2024 to a low of $1.5 million in Q3 2025.
  • A 5-year average of $2.3 million and a median of $2.2 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 161.44% in 2024, then crashed 37.75% in 2025.
  • Neuronetics' Research & Development stood at $1.7 million in 2021, then skyrocketed by 79.99% to $3.1 million in 2022, then decreased by 29.69% to $2.2 million in 2023, then skyrocketed by 161.44% to $5.8 million in 2024, then plummeted by 73.93% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Research & Development are $1.5 million (Q3 2025), $1.8 million (Q2 2025), and $1.6 million (Q1 2025).